Meeting
2016 Genitourinary Cancers Symposium
External beam radiotherapy and concurrent gemcitabine for muscle-invasive bladder cancer: Toxicities and early outcomes.
Authors
Elana Nack
Memorial Sloan Kettering Cancer Center, New York, NY
Elana Nack , Jonathan E. Rosenberg , Bernard H. Bochner , Guido Dalbagni , Michael J. Zelefsky , Marisa Kollmeier
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 443)
DOI
10.1200/jco.2016.34.2_suppl.443
Abstract #
443
Poster Bd #
J14
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Pathologic and survival outcomes following radical cystectomy for “progressive” and “de novo” muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant chemotherapy status.
First Author: Leilei Xia
Poster
2024 ASCO Genitourinary Cancers Symposium
Outcomes with neoadjuvant chemotherapy in bladder-preserving treatment for MIBC.
First Author: Michael Glover
Poster
2023 ASCO Annual Meeting
Survival outcomes in patients with muscle-invasive bladder cancer receiving neoadjuvant chemotherapy stratified by number of cycles.
First Author: Anumita Chakraborty
Poster
2023 ASCO Genitourinary Cancers Symposium
Radical radiotherapy for muscle-invasive bladder cancer: A single centre experience.
First Author: Mayumi Forster